Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Autolus Therapeutics Plc ADR
(NQ:
AUTL
)
1.820
-0.050 (-2.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
296,048
Open
1.840
Bid (Size)
1.820 (3)
Ask (Size)
1.920 (60)
Prev. Close
1.870
Today's Range
1.740 - 1.840
52wk Range
1.600 - 4.730
Shares Outstanding
52,346,231
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Autolus Therapeutics announces resignation of Chief Financial Officer
March 14, 2023
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank
March 13, 2023
From
Autolus Therapeutics plc
Via
Globe NewsWire
Performance
YTD
-2.67%
-2.67%
1 Month
-2.15%
-2.15%
3 Month
+3.41%
+3.41%
6 Month
-12.92%
-12.92%
1 Year
-56.46%
-56.46%
More News
Read More
Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday
March 08, 2023
Via
Benzinga
Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress
March 07, 2023
From
Autolus Therapeutics plc
Via
Globe NewsWire
Earnings Outlook For Autolus Therapeutics
March 06, 2023
Via
Benzinga
Why Autolus Therapeutics Stock Is Crashing Today
December 09, 2022
Via
The Motley Fool
Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023
February 15, 2023
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Therapeutics announces Board changes
January 20, 2023
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
January 09, 2023
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs
December 21, 2022
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022
December 12, 2022
From
Autolus Therapeutics plc
Via
Globe NewsWire
Dow Tumbles 100 Points; Silver Rises Over 2%
December 09, 2022
Via
Benzinga
US Stocks Turn Higher; Nasdaq Rises 40 Points
December 09, 2022
Via
Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
December 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 09, 2022
Via
Benzinga
US Stocks Edge Lower; Producer Prices Increase Higher Than Expected
December 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 09, 2022
Via
Benzinga
Autolus Therapeutics' Leukemia Trial Meets Primary Goal Of Remission Rate, Shares Fall After $150M Capital Raise
December 09, 2022
Via
Benzinga
Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket
December 09, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 09, 2022
Via
InvestorPlace
Autolus Announces Pricing of Public Offering
December 08, 2022
From
Autolus Therapeutics plc
Via
Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 08, 2022
Via
Benzinga
Autolus Announces Proposed Public Offering in the United States
December 08, 2022
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences
December 08, 2022
From
Autolus Therapeutics plc
Via
Globe NewsWire
Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis
December 08, 2022
From
Autolus Therapeutics plc
Via
Globe NewsWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.